ENDRA LIFE SCIENCES INC. Accounts Receivable
ENDRA LIFE SCIENCES INC. (NDRA) had Accounts Receivable of $0 as of 2018-12-31, per its 10-K filed 2019-03-11.
Discontinued › Balance Sheet › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2019-03-11
- 2018-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $0.00.
- 2018-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $12.28K.
- 2018-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $11.77K.
- 2018-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $11.77K.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-11 |
| 2018-09-30 | $12.28K 10-Q · filed 2018-11-05 |
| 2018-06-30 | $11.77K 10-Q · filed 2018-08-13 |
| 2018-03-31 | $11.77K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $6.85K 10-K · filed 2019-03-11 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |